BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
-7.16%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$3.97B
AUM Growth
-$499M
(-11%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
7.73%
Holding
1,278
New
86
Increased
451
Reduced
486
Closed
106
Top Buys
| 1 |
Kennametal
KMT
|
+$11.8M |
| 2 |
V2X
VVX
|
+$11M |
| 3 |
Seadrill
SDRL
|
+$10.4M |
| 4 |
Hamilton Insurance Group
HG
|
+$9.64M |
| 5 |
Werner Enterprises
WERN
|
+$9.1M |
Top Sells
| 1 |
Patrick Industries
PATK
|
+$19.9M |
| 2 |
EchoStar
SATS
|
+$13.1M |
| 3 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$12.4M |
| 4 |
FB Financial Corp
FBK
|
+$11.1M |
| 5 |
Telephone and Data Systems
TDS
|
+$8.57M |
Sector Composition
| 1 | Financials | 29.13% |
| 2 | Industrials | 11.82% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Technology | 10.18% |
| 5 | Energy | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Armata Pharmaceuticals
ARMP
$108M
| $65.2K | ﹤0.01% |
44,682
-25,000
| -36% | -$36.5K |
|
1102
Cabaletta Bio
CABA
$157M
| $63.3K | ﹤0.01% |
45,675
-42,000
| -48% | -$58.2K |
|
1103
Alto Neuroscience
ANRO
$96.7M
| $62.9K | ﹤0.01% |
+29,100
| New | +$62.9K |
|
|
JBIO
1104
Jade Biosciences, Inc. Common Stock
JBIO
$250M
| $62.8K | ﹤0.01% |
714
-1,000
| -58% | -$87.9K |
|
1105
United States Antimony
UAMY
$602M
| $61.2K | ﹤0.01% |
+27,800
| New | +$61.2K |
|
1106
Rallybio
RLYB
$25M
| $60K | ﹤0.01% |
91,600
| – | – |
|
1107
Hyliion Holdings
HYLN
$288M
| $59.5K | ﹤0.01% |
42,500
| – | – |
|
1108
Drilling Tools International
DTI
$70.6M
| $59.3K | ﹤0.01% |
+25,000
| New | +$59.3K |
|
1109
MEI Pharma
MEIP
$101M
| $58.8K | ﹤0.01% |
26,869
| – | – |
|
1110
US Energy Corp
USEG
$39.8M
| $58.6K | ﹤0.01% |
48,848
| – | – |
|
1111
Rani Therapeutics
RANI
$23.4M
| $58.6K | ﹤0.01% |
46,500
-10,000
| -18% | -$12.6K |
|
1112
Century Therapeutics
IPSC
$43.9M
| $57.4K | ﹤0.01% |
120,500
-129,200
| -52% | -$61.5K |
|
1113
Gain Therapeutics
GANX
$61.5M
| $57.3K | ﹤0.01% |
30,004
| – | – |
|
1114
Nine Energy Service
NINE
$30.4M
| $56.5K | ﹤0.01% |
50,000
-42,700
| -46% | -$48.3K |
|
1115
MAIA Biotechnology
MAIA
$51.5M
| $55.1K | ﹤0.01% |
36,000
-9,700
| -21% | -$14.8K |
|
1116
Greenland Technologies Holding Corp
GTEC
$22.3M
| $52.5K | ﹤0.01% |
+30,000
| New | +$52.5K |
|
|
UBX
1117
DELISTED
Unity Biotechnology
UBX
| $52K | ﹤0.01% |
50,000
| – | – |
|
1118
NanoViricides
NNVC
$23.1M
| $51.5K | ﹤0.01% |
44,039
| – | – |
|
1119
Xilio Therapeutics
XLO
$38.7M
| $51.5K | ﹤0.01% |
71,081
| – | – |
|
1120
Harvard Bioscience
HBIO
$20.3M
| $50.7K | ﹤0.01% |
89,517
-39,800
| -31% | -$22.5K |
|
1121
PSQ Holdings
PSQH
$91.8M
| $50.4K | ﹤0.01% |
22,000
| – | – |
|
1122
Optical Cable Corp
OCC
$51.1M
| $49.1K | ﹤0.01% |
17,600
-10,000
| -36% | -$27.9K |
|
1123
ClearOne
CLRO
$7.65M
| $47.5K | ﹤0.01% |
5,454
| – | – |
|
1124
SIFCO Industries
SIF
$43.6M
| $46K | ﹤0.01% |
16,674
| – | – |
|
1125
Ironwood Pharmaceuticals
IRWD
$187M
| $45.6K | ﹤0.01% |
31,000
| – | – |
|